Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma
Authors
Antonio Salar (ORCID: https://orcid.org/0000-0002-4652-4825)
Monica Tani (ORCID: https://orcid.org/0000-0002-5016-2054)
Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma
Antonio Salar, Monica Tani, Joshua Brody, Guillaume Cartron et al.
Citations
6 citations
Journal
Haematologica
Topics
Lymphoma Diagnosis and Treatment
Field-Weighted Citation Impact (FWCI)
2.55
article
Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma
Antonio Salar, Monica Tani, Joshua Brody, Guillaume Cartron, Joaquín Martínez‐López, Carmelo Carlo‐Stella, Aurelien Berthier, Franck Morschhauser, Sirpa Leppä, Emmanuel Bachy, Martine Kallemeijn, Fabiola Bene Tchaleu, Martin Hutchings, Linda Lundberg, James Relf, Nancy L. Bartlett, Lorenzo Falchi, Michael John Dickinson, Cyrus Khan
article en
6 citations
Abstract
No abstract available for this paper.
Publication Tag
HaematologicaVol. 110(4)
Institutions
Roche (Switzerland) (CH), University of Copenhagen (DK), Allegheny Health Network (US), The Royal Melbourne Hospital (AU), Memorial Sloan Kettering Cancer Center (US), University of Helsinki (FI), Humanitas University (IT), The University of Melbourne (AU), Washington University in St. Louis (US), Helsinki University Hospital (FI), Peter MacCallum Cancer Centre (AU), Rigshospitalet (DK), Ospedale "Santa Maria delle Croci" di Ravenna (IT), Centre Hospitalier Universitaire de Montpellier (FR), Hospices Civils de Lyon (FR), Roche (United Kingdom) (GB), Tisch Hospital (US), Hospital Del Mar (ES), Centro de Investigación del Cáncer (ES), Hôpital Claude Huriez (FR), IRCCS Humanitas Research Hospital (IT), Tisch Cancer Institute